Chat real-time with other investors about NCTW, by clicking this link: http://www.stockwire.com/NCTW
NASCENT WINE COMPANY, INC. (OTCBB: NCTW)
Nascent Wine Company, Inc. closed at $0.80 Thursday, trading 100,818 shares
Company News- July 05, 2007: Nascent Foodservice Announces Completion of $11.3 Million Financing with Brookstreet Securities
Nascent Wine Company, Inc., dba Nascent Foodservice, Inc., striving to be the largest food and beverage distributorship in Mexico, announced that on June 28, 2007 it completed a common stock offering of 27,247,500 shares through Brookstreet Securities. Gross proceeds of the offering were $11,299,000, and the net proceeds from the offering to Nascent were $9,830,130.
Sandro Piancone, CEO of Nascent Foodservice, stated, "This financing enables Nascent to execute its business plan ahead of schedule, and position Nascent to take the next steps in becoming the one of the largest food distributors in Mexico."
About Nascent Foodservice, Inc. (OTCBB: NCTW)
Nascent Foodservice is quickly becoming a leading food and beverage distributor throughout Mexico, marketing and distributing over 2,000 national and proprietary brand food and non-food products. Nascent strives to be the leading food and beverage distributor in Mexico and the only national broad-line importer of products into Mexico. Nascent Foodservice also has the exclusive right to distribute Miller Beer in Baja California, Mexico. In addition, Nascent sells select products from Nestle, Haagen-Dazs, General Mills, Ferrarelle Water, Cora Italian Food Products, Bonafont Water, Bonet, Mitsuki, Avasoft Ice Cream, Kabbalah Energy Drink, and Jolly Rancher Soda. Nascent is focused on acquiring the most profitable and well positioned distributors in Mexico with the best food and beverage portfolios in the country, selling to over 7,000 sales points including supermarkets, convenience stores and foodservice accounts. Nascent Foodservice, Inc. trades on the OTC Bulletin Board as Nascent Wine Company, Inc., ticker symbol NCTW.OB.
Chat real-time with other investors about CNOA, by clicking this link: http://www.stockwire.com/CNOA
CHINA ORGANIC AGRICULTURE, INC. (OTCBB: CNOA)
China Organic Agriculture, Inc. closed at $1.21 Thursday, trading 96,600 shares
Company News- July 05, 2007: China Organic Agriculture Announces New Cusip Number, Company Also Began Trading Today Under New Ticker Symbol CNOA
China Organic Agriculture, Inc., a growth-driven agricultural and products company leading China's organic foods revolution, has announced that effective as of July 5, 2007, the Company's new Cusip number will be 16943A103.
About China Organic Agriculture (OTCBB: CNOA)
China Organic Agriculture is among the largest producers of organic rice in China commanding a 40 percent market share. COA controls all aspects of the process from seeds to planting and processing, R&D and sales. The proprietary processing factory is 20,000 square meters and has an annual production capacity of 30,000 tons. The Company also has an extensive sales network, located in the major cities in China. COA, which follows GAAP accounting principles and is fully SEC compliant, has experienced significant growth since its inception in 2002, and has put solid plans in place to markedly expand revenues and increase shareholder value. The quality of COA's products results in the ability to command and receive prices 40% higher than comparables. In the first quarter of 2007 (as of March 31st) the company posted $4.1 million in revenue, up 30 percent from the same period 2006. Gross profit margins grew to 43.9% yielding net income of $1.72 million or 42% of sales. China Organic has in excess of 6260 acres dedicated to green and organic rice. The irrigation system is fed from the Nen River, one of the last unpolluted rivers in China, and no chemicals or fertilizers are used in the process. The Company's flagship brand, ErMaPao has won several quality awards, holds the highest organic certification and is the most popular rice brand in the country. China Organics has the business plan, the depth of management and the capital to realize its mandated goal of becoming the leading organic agriculture company within this explosive sector in China as well as globally within the next five years. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/coa. To view current stock quotes and news, visit http://www.trilogy-capital.com/tcp/coa/quote.html. To view an investor fact sheet about the company, visit http://www.trilogy-capital.com/tcp/coa/factsheet.html. Mission Statement: China Organic Agriculture, Inc. is firmly committed to increasing shareholder value through setting the next generation standard for quality organic food products in China and throughout the world.
Chat real-time with other investors about IXSBF, by clicking this link: http://www.stockwire.com/IXSBF
INNEXUS BIOTECHNOLOGY, INC. (OTCBB: IXSBF)
InNexus Biotechnology Inc. closed at $0.37 Thursday, trading 90,884 shares
Company News- July 05, 2007: InNexus Appoints Dr. Thomas Kindt, Former National Institute of Health (NIH) Director of Intramural Research, as Chief Scientific Officer, Focuses on Commercialization of DXL(TM)
InNexus Biotechnology Inc., a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology, announced the appointment of Dr. Thomas Kindt as Chief Scientific Officer (CSO). Dr. Kindt has been a member of InNexus' Scientific Advisory Board and was most recently Director of Intramural Research and Chief of Laboratory of Immunogenetics at the NIH in Bethesda, Maryland. Dr. Kindt replaces Dr. Kohler who remains a Consultant to the Company.
Jeff Morhet, President and CEO of InNexus said, "This appointment is an important step in communicating the expertise of our team and our mission to commercialize our DXL technology. We are focused on driving projects to the FDA for human trials and concentrating our team and activities on drug development with the assistance of our world class Scientific Advisory Board. Later this year, we will publicly share information about our product development program including InNexus' first pre-clinical stage product candidate for the treatment of cancer."
Commenting on Dr. Kindt's appointment, Dr. Kohler said, "It is now time and I look forward to passing the scientific baton to InNexus' commercial development team. I fully support InNexus' chief goal of commercializing products based on the DXL technology and will continue to serve as a scientific advisor to Mr. Morhet. My best wishes to Jeff, his team and the strategy he has developed for the future of InNexus."
Dr. Kindt was most recently Director of Intramural Research and Chief of Laboratory of Immunogenetics, NIAID, NIH and spent a year as Visiting Scientist, Analytical Immunochemistry Laboratory at the Institute Pasteur, Paris. Prior to this he was with the Rockefeller University in New York and the City of Hope National Medical Center in Duarte, CA. Dr. Kindt has served on a number of Advisory Boards and Committees including those of the Institute Pasteur, Tunis, Tunisia; Hematech LLC, Massachusetts; Institute for Medical Sciences, University of Tokyo; REDI Center, Singapore; NIH Facilities Working Group and Blue Ribbon Panel on Bioterrorism and implications for biomedical research. He has authored and co-authored 225 publications, two books and three patents; currently he is an active biomedical consultant, immunology textbook author and adjunct professor at the University of New Mexico's Department of Biology.
About InNexus (OTCBB: IXSBF)
InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology, which improves the potency of existing antibody products while opening new markets and disease applications. DXL antibodies utilize unique, novel and patented methods and technologies of InNexus. InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona, on the campus of The Mayo Clinic and has its own in-house developmental facilities. These development facilities provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to advance novel drug therapeutics and diagnostics. To learn more about InNexus, please visit www.ixsbio.com.
Chat real-time with other investors about APTD, by clicking this link: http://www.stockwire.com/APTD
ALPHA TRADE.COM (OTCBB: APTD)
AlphaTrade.com closed at $0.23 Thursday, trading 48,500 shares
Company News- July 05, 2007: AlphaTrade Announces the Issuance of 10% Stock Dividend to Its Record Shareholders
AlphaTrade.com announced that all the Company's shareholders of record as of July 27, 2007 (the "Record Date"), shall receive a 10% dividend in the form of the Company's common stock. AlphaTrade will issue the dividend through its registered transfer agent two (2) days after the record date on July 31, 2007, to all shareholders owning APTD stock as of the Record Date. All fractional shares will be rounded up upon the dividend's issuance.
Finalized Stock Dividend Details: Any Persons Wishing to Receive the Ten (10%) Percent Dividend Must be a Recorded Shareholder as of: July 27, 2007. Dividend to Be Paid On: July 31, 2007. All Fractional Shares Will Be Rounded Up Upon the Issuance of the Dividend. Distribution of Additional Shares Will Be Made Through the Transfer Agent of AlphaTrade
About AlphaTrade.com (OTCBB: APTD)
AlphaTrade is an innovator in many fields. In the financial markets - our stock quote service is easy to use, affordable and of superior quality. Our advertising programs connect people and industries in a unique way to provide tangible and measurable results. Companies seeking to expand their brand and gain exposure will appreciate the dynamics of addressing a targeted, niche market and utilizing a variety of digital media tools in combination with a strong financial product to accomplish the task. AlphaTrade today is a top web property that has partnered with some strong sports teams to further its brand and the exposure for their clients: These include the New York Mets (www.mets.com), Tampa Bay Devil Rays (www.devilrays.com), Kenny Bernstein Drag Racing Team (www.kennybernstein.com), Professional Bull Riders (www.pbrnow.com), Huntin' the World Southern Style (www.huntintheworld.com), and the American Drag Racing League (www.adrl.com). Visit www.alphatrade.com to find out more.
Chat real-time with other investors about ITLI, by clicking this link: http://www.stockwire.com/ITLI
INTELLIGENTIAS, INC. (OTCBB: ITLI)
Intelligentias, Inc. closed at $1.21 Thursday, trading 32,300 shares
Company News- July 05, 2007: Intelligentias to Be Featured on Norman Schwarzkopf's World Business Review Series July 8, 2007, on CNBC (as Paid Programming)
Multi-Media Productions (USA), Inc. announces that Intelligentias, Inc. will be featured on World Business Review, hosted by General Norman Schwarzkopf.
In response to terrorism, many law enforcement agencies are turning to data intelligence to help in the fight. Intelligentias products help to quickly investigate and prosecute terrorists. Joining us in this episode of World Business Review is Luigi Caramico, President of Intelligentias to discuss how they are working with the Homeland Security sector.
Senior Coordinating Producer Jay Crosby added, "Intelligentias has partnered with some of the biggest and most reliable names in technology. They sell their software and services to companies world-wide and focus directly on the homeland security sector. Their capabilities made them a natural to appear on World Business Review."
About World Business Review
World Business Review airs on CNBC (as paid programming) and the Bravo! Network (as paid programming). World Business Review may also be viewed through video on demand via www.wbrtv1.com. The WBR Series is also available at more than 90 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University. For more information, please visit www.wbrtv1.com.
About Intelligentias (OTCBB: ITLI)
Intelligentias is a world-wide group of data intelligence Companies. They market Homeland Security products to Law Enforcement Agencies, Telco's ISP's and Enterprises all over the world. With their unique specialization, leading-edge technology and top-tier customer base, Intelligentias qualifies as one of the most dynamic and fastest-growing companies in the Homeland Security sector. For more information please visit www.intelligentias.com
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.